01-05-2006 | Original Articles
Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer
Published in: Clinical and Translational Oncology | Issue 5/2006
Login to get access